Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Day One Biopharmaceuticals Inc
DAWNCurrent price
8.31 USD
+0.12 USD (+1.47%)
Last closed
8.23 USD
Company
dayonebio.com
ISIN
US23954D1090
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
1 272 676 480 USD
Yield for 12 month
-44.67 %
1Y
3Y
5Y
10Y
15Y
DAWN
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California. Address: 2000 Sierra Point Parkway, Brisbane, CA, United States, 94005
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
36.44 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
+93 761 000 USD
Last Quarter
+8 192 000 USD
Current Year
-383 000 USD
Last Year
-531 000 USD
Current Quarter
+92 171 000 USD
Last Quarter
+7 485 000 USD
Key Figures DAWN
1 year
3 years
5 years
10 years
EBITDA
-205 504 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-25.43 %
PEG Ratio
–
Return On Equity TTM
-17.84 %
Wall Street Target Price
36.44 USD
Revenue TTM
101 953 000 USD
Book Value
5.51 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.97 USD
Diluted Eps TTM
-0.97 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-82.68 %
Dividend Analytics DAWN
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History DAWN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Stock Valuation DAWN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
7.03
Price Sales TTM
12.48
Enterprise Value EBITDA
-7.18
Price Book MRQ
2.29
Financials DAWN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators DAWN
For 52 weeks
11.94 USD
18.07 USD
50 Day MA
14.19 USD
Shares Short Prior Month
18 661 330
200 Day MA
14.47 USD
Short Ratio
15.63
Shares Short
19 486 769
Short Percent
23.34 %
BeatStart